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Background: Epilepsy, a chronic disorder of brain characterised by a predisposition to generate epileptic seizures,
has an effect on the psychosocial well-being of sufferers. Measuring the quality of life (QOL) of people with epilepsy
(PWE) is increasingly recognized as an important component of clinical management. QOL measures differ between
countries and there is limited information regarding PWE in Malaysia. The aim of this study was to determine the
health related QOL and its relationship with the presence of seizures in PWE at a Malaysian tertiary referral center.
Methods: A total of 106 adults with epilepsy attending the weekly neurology clinic of Universiti Sains Malaysia
Hospital were interviewed in this cross-sectional study. The QOL was measured using a validated Malay translated
version of the Quality of Life in Epilepsy Scale-31 (QOLIE-31). Analysis of covariance was used for data analysis.
Results: The mean age was 31.8 years old (standard deviation (SD) 11.0) and 56.6% were females. The mean total
score of QOLIE-31was 68.9 (SD 15.9). The highest subscale score was the medication effects with a mean of 79.4
(SD 28.5) and the lowest was seizure worry with 47.5 (SD 25.0). Respondents who had one or more seizures in the
past four weeks had significantly lower mean score of QOL [63.4, 95% CI: 59.2, 67.5] than those who had no seizure
[mean score 73.5, 95% CI: 69.3, 77.9] after adjusting for age, sex, treatment, duration and age at onset of epilepsy [F
test =11.215, p = 0.001, R2 = 0.159]. All the sub-scales of QOL showed significant moderate correlation with the
frequency of seizures except for cognitive functioning.
Conclusions: Worrying about seizure had the major contribution on QOL, while medication effect had the least.
This study confirms the importance of seizure control for a better QOL in Malaysian patients with epilepsy.
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Epilepsy is a common serious neurological disorder,
caused by abnormalities in the electrical activity of the
brain [1]. The diagnosis of epilepsy requires two elements:
a history of at least one seizure and evidence of an endur-
ing alteration in the brain activity [2]. It has been esti-
mated that more than 200 thousand people in Malaysia
suffer from epilepsy [3] but there is a lack of data on the
present prevalence of epilepsy in Malaysia [4].
During the last few decades, greater attention has been
given to the quality of life (QOL) of people with epilepsy
(PWE). They have been shown to report a poorer QOL
compared to the general population because they are
more likely to have poor self-esteem and a high level of* Correspondence: norsaadah@kb.usm.my
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distribution, and reproduction in any mediumanxiety and depression [5]. Social stigma and discrimin-
ation of PWE occur in both developed and developing
countries [5,6]. In many countries, this disorder is still
shrouded in secrecy and patients prefer not to reveal or
discuss their condition [7]. In Malaysia, a survey to assess
public awareness and knowledge reported that even
though there was a high awareness of the condition, many
of the 839 respondents had negative attitudes and poor
knowledge on epilepsy [8]. Previous studies have reported
that QOL of PWE is also influenced by both clinical char-
acteristics (such as frequency, type or presence of seizures,
age of onset and treatment) and socio-demographic vari-
ables (such as sex, marital status, education and employ-
ment) [6,9-11].
Currently, PWE are high users of health care re-
sources, including medications, emergency care services,
hospitalizations, psychological or social services, nursingtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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sionals [12,13]. Understanding the unique and complex
impact of epilepsy on a person’s QOL is also increasingly
recognized as an important component of clinical care
[14] and research in this area will identify factors affect-
ing QOL and may lead to strategies that improve the
management of PWE.
Very few studies have been carried out on epilepsy
and none have been published on measurement of QOL
in PWE in Malaysia. Different countries have dissimilar-
ities of beliefs, culture and socio-economic factors which
in turn can affect QOL measures, thus findings from
other countries, may not be relevant to the local situ-
ation. This study was conducted to determine the level
of health related QOL of PWE under follow-up in
Hospital Universiti Sains Malaysia (HUSM).
Methods
HUSM is a teaching hospital located in north-eastern pen-
insular Malaysia. It is a tertiary referral center for the area
and serves a population that has a lower socio-economic
status compared to the population in the capital city Kuala
Lumpur located on the west coast of peninsular Malaysia.
Annually there are about 800 consultations by PWE at the
neurology clinic and the interval for routine follow-up is
approximately three months.
This was a cross sectional study in design. Respon-
dents were adults aged at least 18 years old with a diag-
nosis of epilepsy who were attending follow-up at the
neurology clinic during the study period. We included
all types of epilepsy that had been diagnosed for at least
a year; respondents also had to be seizure free for
24 hours and consented to participate in the study. We
excluded people with psychotic disorders, severe mental
retardation, strokes, head injuries, brain tumors and pa-
tients who have had recent brain surgery.
Questionnaires were developed to collect socio-
demographic data (age, sex, marital status, employment
status, educational level and monthly household in-
come) and clinical aspects of epilepsy (frequency, type
and presence of seizures, the age of onset, duration of
epilepsy, etiology and medication). Seizures frequency
was defined as the number of seizures occurring in the
four weeks prior to the interview. We also collected data
on co-morbidity of other chronic diseases such as dia-
betes, hypertension and asthma.
QOLIE-31was used for collecting data on health related
QOL with the permission of the RAND Corporation.
QOLIE-31consists of seven subscales which are seizure
worry (five items), emotional well-being (five items), en-
ergy / fatigue (four items), cognitive functioning (six
items), medication effects (three items), social functioning
(five items), overall QOL (two items) and one item of
overall health [15]. The responses used Likert rating scaleswhich were later transformed into linear scales that ranged
between 0 and 100. A higher score indicates better quality
of life.
The translation of QOLIE-31into Malay version was
done by two individuals who are fluent in both the
English and Malay languages. The new Malay version of
QOLIE-31was back-translated into English to ensure
that the meaning and comprehension of the original ver-
sion was retained. The Malay version of QOLIE-31was
also checked for both the accuracy and meaning of the
translated versions before being finalized. A pretest was
conducted on 20 PWE to ensure that the translated ques-
tionnaire was easy to understand. The overall Cronbach’s
alpha score was 0.697. The scoring and weightage of each
item in the QOLIE-31 was obtained from the guidelines in
the QOLIE-31 manual [15]. The total scores of subscales
and total QOL are presented in the results section.
The Research and Ethics Committee of Universiti Sains
Malaysia approved this study and all data pertaining to the
study were kept confidential. Written informed consent
was obtained from the patients for the participation in this
research and publication of the findings. Data were ana-
lyzed using the Statistical Package of Social Sciences (SPSS)
version 12.0. Descriptive statistics were expressed as mean
(standard deviation (SD)) and frequency (percentage) as ap-
propriate. The independent t- test or one-way analysis of
variance (ANOVA) was used to compare means of QOL
scores between groups. Analysis of covariance (ANCOVA)
was used to compare the means of QOL scores between
the presence of seizures with the adjustment of age, sex,
treatment, duration and age of onset. Correlation coeffi-
cient was used to measure the relationship between fre-
quency of seizures and total score of QOLIE-31. The level
of significance was set at p value < 0.05.
Results
Out of a total of 120 PWE approached, 106 fulfilled all
the inclusion and exclusion criteria and were included in
the analysis. The age of respondents ranged from 18 to
62 years old with the mean (SD) of 31.8 (11.0) years.
More than half were female (56.6%). The range of sei-
zures frequency in the past 4 weeks was 0–8, with mean
(SD) of 1.09 (1.52). The mean (SD) age at onset of epi-
lepsy and duration of epilepsy were 17.2 (13.5) and 14.1
(9.0) years respectively.
Table 1 shows the mean and SD scores of QOLIE-31
subscales. The mean (SD) total score of QOLIE-31 was
68.9 (15.9). The highest mean (SD) score was the medi-
cation effects, 79.4 (28.5) and the lowest was seizure
worry subscale, 47.5 (25.0). One-way ANOVA showed
significant differences in the mean score of sub-scales of
QOLIE-31 (p < 0.001). There were significant differences
between subscales scores in post-hoc tests. The total
score of seizure worry and medication effects were
Table 1 Total score of QOLIE-31 sub-scales
Subscales of QOLIE-31 Mean (SD)
score
Cronbach's
Alpha
Seizure worry 47.5 (25.0) 0.766
Overall quality of life 72.8 (15.0) 0.614
Emotional well-being 70.1 (18.8) 0.692
Energy/fatigue 64.9 (19.6) 0.679
Cognitive functioning 70.2 (21.1) 0.779
Medication effects 79.4 (28.5) 0.796
Social functioning 72.9 (25.4) 0.819
Subjective overall health (Item 31 – visual
analogue scale)
75.9 (16.6)
Total Score 68.9 (15.9) 0.697
One-way ANOVA, F test =21.376, p-value <0.001.
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31 (p < 0.001). The table also shows the results of the
Cronbach's Alpha for each sub-scale.
Tables 2 and 3 show the different total QOL scores for
groups with different socio-demographic and clinical char-
acteristics. There were no significant differences in the
mean of total QOL scores between groups for socio-Table 2 Differences of QOL score for socio-demographic
characteristics of the respondents
N (%) Total QOL
score
p-value
Mean (SD)
Age (years) 0.597a
18-25 39 (36.8) 68.7 (15.9)
26-35 31 (29.2) 67.0 (13.6)
36-62 36 (34.0) 70.9 (18.0)
Sex 0.201b
Male 46 (43.4) 66.7 (15.7)
Female 60 (56.6) 70.7 (16.0)
Marital status 0.591b
Single 64 (60.4) 68.3 (14.9)
Ever married 42 (39.6) 70.0 (17.5)
Employment status 0.985b
Employed 39 (36.8) 69.0 (17.5)
Unemployed 67 (63.2) 68.9 (15.1)
Educational level 0.641a
Lower secondary or lower 37 (34.9) 66.9 (17.8)
High secondary 48 (45.3) 69.8 (12.1)
Higher than high secondary 21 (19.8) 70.4 (20.3)
Monthly household income (RM) 0.330a
<500 21 (19.8) 64.3 (16.7)
500-1,000 61 (57.5) 70.2 (15.7)
>1,000 24 (22.7) 69.7 (15.7)
aOne-way ANOVA, bindependent t test.demographic and clinical characteristics except frequency
of seizures. ANCOVA analysis confirmed a significant
mean difference in the total score of QOLIE-31with the
occurrence of seizures in the past four weeks [F test
=11.215, p = 0.001, R2 = 0.159], after adjusting age, sex,
treatment, duration and age at onset of epilepsy. Respon-
dents who had no seizure in the past four weeks had
higher QOL [mean score 73.5, 95% CI: 69.3, 77.9] than
those had seizure [mean score 63.4, 95% CI: 59.2, 67.5].
Table 4 shows the correlation between seizures frequency
and total score and sub-scales of QOLIE-31. All the sub-
scales showed significant moderate correlation with the
seizures frequency except cognitive functioning which
showed weak correlation.
Table 5 shows the distribution of anti-epileptic drugs
used by the respondents. More than half were on
monotherapy and the most frequently used medica-
tions were sodium valproate, followed by carbamaze-
pine and lamotrigine.
Discussion
The mean total score of QOLIE-31 in our study [68.9
(SD15.9)] was higher than other studies conducted in
Moscow [42.13 (SD 4.14)] [6], Australia [52.9 (SD 23.1)
[16], Togo [49.5 (SD 14.4)] and Benin, Africa [52.1
(33.4)] [17]. Malaysia is a country which has specialist-
physician run services for PWE [18] and this may have
contributed to a better standard of medical care, perhaps
resulting in a better HRQOL score. It must be noted,
however, that even though the studies cited had used the
QOLIE-31 questionnaire (different translations) or
QOLIE −89 questionnaire (the other questionnaire for
measuring QOL in epilepsy patients from the RAND
corporation), different study methodologies with differ-
ent inclusion and exclusion criteria could also account
for the different scores.The pattern of scores of QOLIE-
31 subscales of our study was similar to the studies
conducted in Africa [17] with medication effects having
the highest score while seizure worry had the lowest. In
Australia where the respondents studied were generally
older, the social function subscale was the highest and
energy/fatigue was the lowest score [16]. This difference
in patterns is likely due to differences in sociocultural or
clinical factors and it has been shown that country of
origin has an effect on quality of life scores [19]. Al-
though direct comparison between QOL scores of differ-
ent countries is not advisable, finding a QOL score that
is not too dissimilar to other countries is somewhat
reassuring.
The subscales of the translated QOLIE-31 question-
naire showed satisfactory (more than 0.7) Cronbach’s
Alpha scores were seizure worry, cognitive functioning,
medication effects and social functioning. Emotional
functioning and energy/fatigue had scores that were
Table 3 Differences of QOL score for clinical
characteristics of the respondents
N (%) Total QOL
score
p-value
Mean (SD)
Age of onset (year) 0.096a
<10 30 (28.3) 69.6 (16.0)
10-25 50 (47.2) 65.0 (16.4)
>25 26 (24.5) 74.1 (13.8)
Type of seizure 0.982b
Partial 27 (25.5) 69.0 (17.0)
Generalised 79 (74.5) 68.9 (15.7)
Duration of epilepsy (year) 0.379a
<5 15 (14.2) 73.0 (14.0)
5-20 69 (65.1) 69.1 (15.0)
>20 22 (20.7) 65.6 (19.6)
Treatment 0.131b
Monotherapy 61 (57.5) 70.9 (16.0)
Polytherapy 45 (42.5) 66.2 (15.6)
Co-morbidity 0.871b
No 87 (82.1) 69.2 (15.8)
Yes 19 (17.9) 67.7 (17.1)
Family history 0.891b
No 94 (88.7) 68.9 (16.0)
Yes 12 (11.3) 69.5 (16.1)
Etiology 0.811b
Idiopathic 55 (51.9) 69.3 (16.5)
Other factors 51 (48.1) 68.5 (15.4)
Presence of seizure in past 4 weeks <0.001b
Absent 54 (50.9) 74.3 (14.1)
Present 52 (49.1) 63.3 (15.9)
aOne-way ANOVA, bindependent t test.
Table 4 Correlation between frequency of seizures and
total score of QOLIE-31 sub-scales
Subscales of QOLIE-31 Correlation coefficient P value
Seizure worry 0.431 <0.001
Overall functioning 0.368 <0.001
Emotional well-being 0.382 <0.001
Energy/fatigue 0.382 <0.001
Cognitive functioning 0.190 0.051
Medication effects 0.390 <0.001
Social functioning 0.359 <0.001
Total Score 0.436 <0.001
Table 5 Anti-epileptic drugs used by the respondents
Anti-epileptic drug No (%)
Sodium valproate 56 (52.8)
Carbamazepine 31 (29.2)
Lamotrigine 28 (26.4)
Levetiracetam 18 (17.0)
Phenytoin 16 (15.1)
Clonazepam 5 (4.7)
Topiramate 4 (3.8)
Phenobarbitone 1 (0.9)
One type 61 (57.6)
Two types 38 (35.8)
Three types 7 (6.6)
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only two items, scored 0.6. These satisfactory scores for
the items in the subscales may attest to the validity of
the translated questionnaire.
Nearly half of our respondents had at least one episode
of seizure in the past four weeks, which is a poor result
when compared to a study in Iran, the Gulf and Near East
that reported only 25% of epilepsy respondents having one
or more seizures per month [5]. Being a tertiary centre, it
is possible that our respondents were more complicated
cases compared to the respondents in that study who were
sourced from hospital outpatients.
Only seizures frequency was found to have a significant
effect on the QOL score among all the clinical characteris-
tics that were measured. No socio-demographic character-
istic was found to be of significance. There were significant
weak and moderate correlations between seizuresfrequency and all the QOL sub-scales except for cognitive
functioning (P = 0.051). The correlation strength between
scores of subscales and seizures frequency in our study
were stronger compared to a study in Moscow [6] which
also found a significant relationship between seizures fre-
quency and QOL. In general, the literature supports the
finding of our study in which people with frequent seizures
had significantly poorer HRQOL than those with infre-
quent or no seizures [10,11,17,19-22]. Baker et al. reported
that seizures frequency was the most important clinical
predictor of psycho-social dysfunction and emotional mal-
adjustment in PWE [9]. McLaughlin et al. concluded that
even infrequent seizure might impair health related QOL
in older PWE [16]. People with uncontrolled epileptic sei-
zures will always be in the uncomfortable position of not
knowing when the next seizure will occur and may take
precautions and impose restrictions to avoid of having sei-
zures at inappropriate times, public places or social events.
They can be restricted from driving, and may be denied
job and career opportunities which can translate into a
lower QOL. The threat of recurrent seizures and the fear
of social embarrassment and rejection can be lifelong con-
cerns for PWE. There is a hazard of injury during a seizure
that may also affect their QOL. Our study also showed that
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the sub-scales of QOLIE-31.
Frequency of seizures has been related to fear and mis-
understanding which results in the social stigma and dis-
crimination surrounding epilepsy. A study in Zambia
reported that many PWE were feared and rejected by fam-
ilies or communities [23].Cultural beliefs influence atti-
tudes and actions of the community towards PWE [8,24]
and high rates of anxiety, depression, and low self-esteem
have been measured in PWE, thus adversely affecting
quality of life [25]. In Malaysia, a study of university stu-
dents reported that many students could not differentiate
between mental illness and epilepsy and it was common
to use many insanity related terms to describe PWE [26].
It seems that even in a setting of higher education, there is
a lack of understanding of epilepsy and greater efforts are
needed to raise awareness and understanding about the
condition for the general public by the local authorities.
Longer duration of epilepsy has been reported as a
predictor for poor QOL [9,21]. The longer duration of
epilepsy may be related to greater complications and
disabilities. Our study found no significant association
between duration of epilepsy and QOL, although there
was a trend of lower scores of QOL in those with lon-
ger duration of epilepsy. The number of respondents in
our study was quite small in number compared to the
study by Baker et al. [9] and there were more women in
our sample compared to the study by Djibuti et al. [21].
There were more respondents with generalized than
partial seizures in our study. The type of seizure has
not been shown to be an important predictor factor of
QOL [9,27] and this was also found in our study.
Less seizures frequency has been related to a greater
likelihood of being employed [28]. More than half of our
respondents reported being unemployed. The reasons
for unemployment are multi-factorial, and are related to
the state of seizure control, the age of onset and dur-
ation of illness, the type of medication, severity and fre-
quency of seizures [20,28]. It is likely that a person with
epilepsy diagnosed in childhood would have many
schooling hours disrupted if the frequency of seizures
were uncontrolled and this could also lead to low educa-
tional achievement and thus a lower employability po-
tential. Occupational related stress such as assignment
deadlines and criticisms by supervisors may trigger sei-
zures. Furthermore, a seizure itself may cause accidents
and injuries thus preventing sufferers from driving and
depriving many types of employment opportunities. Em-
ployers are unlikely to employ a person with epilepsy if
they are experiencing seizures that interfere with job
performance.
Our study did not find any significant differences in the
QOLIE-31 and the presence of co-morbidities as sup-
ported by Alanis-Guevara et al. [10]. Psychiatric diseasessuch as depression and mood disorders have been reported
to be common among PWE and are important determi-
nants of QOL [22,29]. The presence of co-morbidities in
our study was confirmed only by reviewing the general
medical records, which was one of our study limitations.
We did not use specific tools to measure psychiatric co-
morbidity as was done in studies that identified such co-
morbidities as significant predictors of QOL.
Seizure remission is possible with appropriate type
and dose of long term antiepileptic drugs (AEDs). PWE
who were treated with AEDs had significantly better
QOL than the untreated people [16]. Monotherapy has
been recognized to be able to control seizures ad-
equately and polytherapy is only necessary in the mi-
nority of people with more severe seizures. A study in
Malaysia reported that the percentage of people that re-
ceived monotherapy was nearly double than those with
polytherapy [3]. In our study, 57.5% was on a single
drug therapy, 35.8% on two types, 6.6% on three and
none on four types of AED. In comparison, an Iranian
study reported that 61% of their respondents were re-
ceiving monotherapy, 29% were taking two, 7% were
taking three and 1% were taking four of five AEDs [5].
It has been reported that there was no association be-
tween polytherapy with QOLIE-31 [6,10,27] and this is
also confirmed in our study, respondents who were on
polytherapy did not have poorer HRQOL compared to
those on monotherapy. There is evidence that suggests
PWE who are seizure free without significant adverse
drug effects have QOL measures as good as individuals
without epilepsy [19].
Our study used a Malay version of QOLIE-31 that
had a satisfactory reliability test. QOLIE-31 is an accur-
ate, specific and complete measurement for HRQOL
among PWE [15,21]. It has been designed as a brief for-
mat to assess health related QOL among PWE; and is
an easily scored questionnaire that has been tested in
many languages and populations [15]. It can be used as
a tool for clinicians and researchers to determine the
magnitude of the effect of interventions on QOL. We
have shown that frequency of seizures is a predictor of
QOLIE-31 scores, therefore if QOL measures are to be
used to assess between different treatment regimens in
Malaysia, comparisons should be done with patients
stratified into those with controlled and uncontrolled
seizures
This study aimed to assess the HRQOL of PWE and
only sourced the data from the neurology clinic of
HUSM, thus, the results may not be generalized to PWE
in Malaysia. All the respondents were on follow up at a
tertiary level academic hospital, and may have been re-
fractory to first-line treatment or having other complica-
tions that might affect their QOL compared to PWE
who were on follow up in primary care centers.
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Malaysia is still needed. Comparison of HRQOL be-
tween PWE and controls as well as to identify the psy-
chiatric co-morbid conditions that may affect QOL
scores could be very useful as many psychiatric co-
morbid conditions can be managed with non-drug
regimens.
Epilepsy often begins at a young age and affects young
people in their most productive years of their lives and
can affect their social and cognitive development.
Worrying about seizure was a significant subscale of
the QOLIE-31 while medication effects had the least,
thus, effective control of seizures frequency is essential
to improve the HRQOL scores. The management of
PWE should be aimed at both preventing seizures and
reintegrating sufferers into community life. Public edu-
cational campaigns should be conducted in order to
raise awareness of the public regarding the existence of
effective therapy and eliminate the stigma of epilepsy.
In conclusion, this study confirmed the findings of
other studies regarding the importance of controlling
seizures for a better QOL of PWE.
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